APA (7th ed.) Citation

Lenglet, T., Lacomblez, L., Abitbol, J. L., Ludolph, A., Mora, J. S., Robberecht, W., . . . Meininger, V. (2014). A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis. European journal of neurology, 21(3), 529-536. https://doi.org/10.1111/ene.12344

Chicago Style (17th ed.) Citation

Lenglet, T., et al. "A Phase II−III Trial of Olesoxime in Subjects with Amyotrophic Lateral Sclerosis." European Journal of Neurology 21, no. 3 (2014): 529-536. https://doi.org/10.1111/ene.12344.

MLA (9th ed.) Citation

Lenglet, T., et al. "A Phase II−III Trial of Olesoxime in Subjects with Amyotrophic Lateral Sclerosis." European Journal of Neurology, vol. 21, no. 3, 2014, pp. 529-536, https://doi.org/10.1111/ene.12344.